INTRAOPERATIVE MEASUREMENT OF ADRENOCORTICOTROPIN (ACTH) DURING REMOVAL OF ACTH-SECRETING BRONCHIAL CARCINOID-TUMORS

被引:18
作者
RAFF, H
SHAKER, JL
SEIFERT, PE
WERNER, PH
HAZELRIGG, SR
FINDLING, JW
机构
[1] ST LUKES HOSP, ENDOCRINE RES LAB, MILWAUKEE, WI 53215 USA
[2] ST LUKES HOSP, DEPT CARDIOVASC & THORAC SURG, MILWAUKEE, WI 53215 USA
[3] MED COLL WISCONSIN, DEPT MED, MILWAUKEE, WI 53226 USA
关键词
D O I
10.1210/jc.80.3.1036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The optimal treatment for ectopic ACTH syndrome is the complete removal of the tumor secreting ACTH. These tumors are often occult, with their location suggested but not proven with imaging techniques. The intraoperative measurement of ACTH by immunoradiometric assay in five patients with the occult ectopic ACTH syndrome during removal of suspicious intrapulmonary lesions is reported. A significant ACTH gradient was detected in the pulmonary veins of the affected lobes in two patients. ACTH had decreased significantly in all five patients by 10 and 15 min after tumor removal. All five patients had histologically proven ACTH-secreting bronchial carcinoid tumors, suppressed plasma ACTH by 24 h after tumor removal, and subsequent secondary adrenal insufficiency indicating successful surgical therapy (five of five true-positive). In one patient, previous surgery was not curative and did not result in a decrease in intraoperative measurement of ACTH (one of one true-negative). It was demonstrated that a rapid ACTH immunochemiluminescence assay with a 15-min incubation time has sufficient sensitivity and precision to detect decreases in ACTH described above. These results demonstrate that complete removal of ACTH-secreting bronchial carcinoid tumors can be detected intraoperatively by a decrease in arterial ACTH by 15 min. The modification of the ACTH immunochemiluminescence assay to 15 min incubation allows the documentation of a successful tumor removal in the operating room. It may also be used to locate the tumor intraoperatively by selective pulmonary vein sampling. This protocol may be applicable to the intraoperative measurement of ACTH during pituitary microadenomectomy for Cushing's disease.
引用
收藏
页码:1036 / 1039
页数:4
相关论文
共 17 条
[1]   DETECTION OF ACTH-PRODUCING BRONCHIAL CARCINOID-TUMORS - MR IMAGING VS CT [J].
DOPPMAN, JL ;
PASS, HI ;
NIEMAN, LK ;
FINDLING, JW ;
DWYER, AJ ;
FEUERSTEIN, IM ;
LING, A ;
TRAVIS, WD ;
CUTLER, GB ;
CHROUSOS, GP ;
LORIAUX, DL .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1991, 156 (01) :39-43
[2]   THE USE OF IMMUNORADIOMETRIC ASSAY FOR THE MEASUREMENT OF ACTH IN HUMAN PLASMA [J].
FINDLING, JW ;
ENGELAND, WC ;
RAFF, H .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1990, 1 (06) :283-287
[3]   ROUTINE INFERIOR PETROSAL SINUS SAMPLING IN THE DIFFERENTIAL-DIAGNOSIS OF ADRENOCORTICOTROPIN (ACTH)-DEPENDENT CUSHINGS-SYNDROME - EARLY RECOGNITION OF THE OCCULT ECTOPIC ACTH SYNDROME [J].
FINDLING, JW ;
KEHOE, ME ;
SHAKER, JL ;
RAFF, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (02) :408-413
[4]   OCCULT ECTOPIC SECRETION OF CORTICOTROPIN [J].
FINDLING, JW ;
TYRRELL, JB .
ARCHIVES OF INTERNAL MEDICINE, 1986, 146 (05) :929-933
[5]  
FINDLING JW, 1985, PITUITARY GLAND, P441
[6]   INTRAOPERATIVE MONITORING OF PARATHYROID PROCEDURES BY A 15-MINUTE PARATHYROID-HORMONE IMMUNOCHEMILUMINOMETRIC ASSAY [J].
KAO, PC ;
VANHEERDEN, JA ;
TAYLOR, RL .
MAYO CLINIC PROCEEDINGS, 1994, 69 (06) :532-537
[7]   RELATIONSHIP OF BIOASSAYABLE AND IMMUNOASSAYABLE PLASMA ACTH AND CORTISOL CONCENTRATIONS IN NORMAL SUBJECTS AND IN PATIENTS WITH CUSHINGS-DISEASE [J].
KRIEGER, DT ;
ALLEN, W .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1975, 40 (04) :675-687
[8]   PITUITARY SURGERY [J].
LAWS, ER .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1987, 16 (03) :647-665
[9]   DIAGNOSIS OF CORTICOTROPIN-PRODUCING BRONCHIAL CARCINOID-TUMORS CAUSING CUSHINGS-SYNDROME [J].
LEINUNG, MC ;
YOUNG, WF ;
WHITAKER, MD ;
SCHEITHAUER, BW ;
TRASTEK, VF ;
KVOLS, LK .
MAYO CLINIC PROCEEDINGS, 1990, 65 (10) :1314-1321
[10]  
LUDECKE DK, 1990, PROG ENDOC, V5, P261